Objetivo ALBYN MEDICAL has developed, in cooperation with the Chemnitz University of Technology and the University Hospital of Cologne (Germany), a specific diagnostic system for the Overactive Bladder syndrome. This diagnostic device is implanted by cystoscopy and measures the bladder pressure autonomously, relating the bladder pressure with the urination, controlled or not, and it determines if the pressure rise appears only when a voluntary urination occurs or if also occurs other times as in the accidental urine loss.Thanks to the new diagnostic device a reliable diagnostic evaluation is obtained and thus high treatment costs of the current Overactive Bladder over-diagnosis are avoided improving the sustainability of the European Health and Care systems. Ámbito científico medical and health sciencesclinical medicineoncologybladder cancersocial scienceseconomics and businessbusiness and managementbusiness models Programa(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.3. - Treating and managing disease Tema(s) PHC-12-2014-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Convocatoria de propuestas H2020-SMEInst-2014-2015 Consulte otros proyectos de esta convocatoria Convocatoria de subcontratación H2020-SMEINST-1-2014 Régimen de financiación SME-1 - SME instrument phase 1 Coordinador ALBYN MEDICAL, S.L. Aportación neta de la UEn € 50 000,00 Dirección Poligono Industrial de Cordovilla D1 31191 Cordovilla España Ver en el mapa Pyme Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención. Sí Región Noreste Comunidad Foral de Navarra Navarra Tipo de actividad Private for-profit entities (excluding Higher or Secondary Education Establishments) Enlaces Contactar con la organización Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 71 429,00